ロード中...
Biomarkers in phase I–II chemoprevention trials: lessons from the NCI experience
Early phase clinical trials are an essential component of chemopreventive drug development to identify signals of drug efficacy that can subsequently be explored definitively in phase III trials. Whereas phase I trials focus on safety and identification of optimal dose and schedule for cancer preven...
保存先:
| 出版年: | Ecancermedicalscience |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cancer Intelligence
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4664504/ https://ncbi.nlm.nih.gov/pubmed/26635903 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.599 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|